- July 28, 2021
Mason's Michael Buschmann and his team have developed technology that could help make COVID-19 vaccines less costly, with fewer side-effects and more available.
Mason's Michael Buschmann and his team have developed technology that could help make COVID-19 vaccines less costly, with fewer side-effects and more available.